John Schieszer

Most Recent Articles by John Schieszer

LDR Brachytherapy for PCa Yields Excellent Outcomes

LDR Brachytherapy for PCa Yields Excellent Outcomes

By

Long-term data show a local disease recurrence rate of 2.1% at 10 years.

Genetic Differences in Prostate Cancer Pinpointed in Black Men

Genetic Differences in Prostate Cancer Pinpointed in Black Men

By

New findings could help explain why men of African ancestry are more likely than white men to die from prostate cancer.

Study Zeroes in on Cause of Castration-Resistant Prostate Cancer

Study Zeroes in on Cause of Castration-Resistant Prostate Cancer

By

Some prostate cancer cells lack androgen receptor, and they proliferate faster than those that express androgen receptor under androgen-deficient conditions.

Advances in Imaging, Therapies Bode Well for nmCRPC Management

Advances in Imaging, Therapies Bode Well for nmCRPC Management

By

Novel imaging and tumor biomarker assays are likely to define non-metastatic castration-resistant prostate cancer more accurately, authors of new review state.

Shorter ADT Course May Suffice for High-Risk Prostate Cancer

Shorter ADT Course May Suffice for High-Risk Prostate Cancer

By

New study shows no significant difference in overall survival between 18 and 36 months of androgen deprivation therapy used in combination with radiation therapy.

More Articles by John Schieszer

Sign Up for Free e-newsletters